Paciente neonato a término con enfermedad de membrana hialina.
| dc.contributor.advisor | Sandoya Vite, Glenda Azucena | |
| dc.contributor.author | León Mayorga, Siulee Stefany | |
| dc.date.accessioned | 2021-10-20T16:16:02Z | |
| dc.date.available | 2021-10-20T16:16:02Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/10248 | |
| dc.description | This work offers current information on what is this condition that neonates go through, how to approach this patient, both the pediatric physician and the health personnel. The methodology to be used to help the neonate to improve his situation. To be clear that hyaline membrane disease is caused by a deficit in the production of surfactant, which does not allow the recruitment of the alveolar unit and normal gas exchange. The main risk factor is prematurity; however, perinatal asphyxia, maternal diabetes, absence of antenatal corticosteroids, among others, also influence its presentation. | es_ES |
| dc.description | This work offers current information on what is this condition that neonates go through, how to approach this patient, both the pediatric physician and the health personnel. The methodology to be used to help the neonate to improve his situation. To be clear that hyaline membrane disease is caused by a deficit in the production of surfactant, which does not allow the recruitment of the alveolar unit and normal gas exchange. The main risk factor is prematurity; however, perinatal asphyxia, maternal diabetes, absence of antenatal corticosteroids, among others, also influence its presentation. | es_ES |
| dc.description.abstract | Este trabajo ofrece información actual sobre que es este padecimiento por el que pasan los neonatos, como abordar a este paciente tanto el medico pediátrico, como el personal de salud. La metodología que se utilizara para ayudar al neonato a mejorar su situación. Tener en claro que la enfermedad de la membrana hialina es a causa por un déficit en la producción de surfactante, lo que no le permite el reclutamiento de la unidad alveolar y el intercambio gaseoso con normalidad. El principal factor de riesgo es la prematurez, sin embargo, también influyen en su presentación la asfixia perinatal, diabetes materna, ausencia de corticoides antenatales, entre otros. | es_ES |
| dc.format.extent | 27 p | es_ES |
| dc.language.iso | es | es_ES |
| dc.publisher | Babahoyo: UTB-FCS, 2021 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
| dc.subject | Neonato | es_ES |
| dc.subject | Déficit de surfactante | es_ES |
| dc.subject | Prematuro | es_ES |
| dc.subject | Enfermedad de la membrana hialina | es_ES |
| dc.title | Paciente neonato a término con enfermedad de membrana hialina. | es_ES |
| dc.type | bachelorThesis | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Ecuador